Mechelen Belgium; 7 May 2017 16.35 CET Galapagos NV Euronext & NASDAQ GLPG announces the presentation of three posters from the Phase 2 FITZROY study of the investigational agent filgotinib in Crohn's Disease at Digestive Disease Week DDW1 2...
↧